Chuck Royce's SOPH Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 3.38 M shares of SOPHiA GENETICS SA (SOPH) worth $19.51 M, representing 0.16% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Chuck Royce has maintained this position in SOPH for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 1.57 M shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's SOPHiA GENETICS (SOPH) Holding Value Over Time
Track share changes against reported price movement
Quarterly SOPHiA GENETICS (SOPH) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.57 M | Add 86.19% | 3.38 M | $5.77 |
| Q1 2026 | +1.39 M | Add 322.15% | 1.82 M | $4.95 |
| Q4 2025 | +430,257 | New Buy | 430,257 | $4.67 |
Chuck Royce's SOPHiA GENETICS Investment FAQs
Chuck Royce first purchased SOPHiA GENETICS SA (SOPH) in Q4 2025, acquiring 430,257 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held SOPHiA GENETICS SA (SOPH) for 3 quarters since Q4 2025.
Chuck Royce's largest addition to SOPHiA GENETICS SA (SOPH) was in Q2 2026, adding 3,381,736 shares worth $19.51 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 3,381,736 shares of SOPHiA GENETICS SA (SOPH), valued at approximately $19.51 M.
As of the Q2 2026 filing, SOPHiA GENETICS SA (SOPH) represents approximately 0.16% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in SOPHiA GENETICS SA (SOPH) was 3,381,736 shares, as reported at the end of Q2 2026.